Bill Allan – CEO
Bill is an internationally- experienced medical devices executive who has held a number of general management and leadership positions with global medical device companies, including Smith & Nephew, Angiodynamics, Orthovita and Stryker. He has a strong track record of building businesses and launching new products and has worked in Europe, Africa and North America.
Educated at the University of Edinburgh,University of Capetown and Insead Business School, Bill is a mentor at Cambridge University (Judge) Business School and a council member of ABHI (Association of British Healthcare Industries).
Kate Full – Company Secretary
Kate joined Vascular Flow Technologies from Braveheart Ventures where she was responsible for the evaluation and development of investment opportunities, focusing on financial diligence. A Chartered Certified Accountant, she trained with PriceWaterhouseCoopers, qualifying in 2001 and continued in professional practice until joining Braveheart in 2004. Prior to embarking on her professional training Kate held a number of different accounting roles in a variety of industries including manufacturing, wholesale and leisure.
Graeme Houston – Non-executive Medical Director
As Chair of Clinical Imaging and Intervention, University of Dundee, Professor Houston is a Consultant Cardiovascular Radiologist with an interest in endo-vascular therapies, and non-invasive vascular imaging using MRI and Ultrasound. His medical training at St. Thomas’s Hospital in London followed first class honours science degrees in physics and pathology at Cambridge University. His endo-vascular training was undertaken initially in Glasgow and further developed as Fellow in University of British Columbia, Vancouver, Canada. He is responsible for intellectual property, and as Medical Director is responsible for the clinical scientific research in the Spiral Laminar Flow™ field and stent technology.